期刊文献+

甘肃地区缺血性脑卒中患者卒中认知调查及影响因素分析 被引量:8

A survey of stroke awareness and influential factors among acute ischemic stroke patients in Gansu Province
下载PDF
导出
摘要 目的调查缺血性卒中患者对卒中危险因素、预警症状及溶栓治疗认知情况,并探索影响卒中认知的相关因素。方法自2015年3月至2015年9月期间,使用结构式问卷横断面调查缺血性卒中患者对卒中的认知,分析卒中认知与可能影响卒中认知的相关因素,采用单因素及多因素回归分析探索影响缺血性卒中患者卒中认知的因素。结果共调查了138例就诊于兰州大学第一医院神经内科的缺血性卒中患者,年龄(63.53±11.41)岁,男性89例(60.1%)。认知率最高的卒中危险因素是高血压(64.5%),卒中症状是偏侧肢体无力(60.1%);知道溶栓治疗5.8%,知道溶栓治疗时间窗为1.4%。单因素回归分析显示文化程度与识别3个及以上卒中危险因素(P=0.036)和卒中症状(P=0.042)、知道溶栓治疗(P=0.045)及时间窗(P=0.017)都有关。多因素回归分析显示发病时能识别卒中症状(OR=0.252,P=0.012)是识别3个及以上卒中危险因素的独立预测因素;使用非正规降压药物(OR=1.344,P=0.024)和发病后急诊转运途径(OR=0.662,P=0.05)是识别3个及以上卒中症状的独立预测因素;发病时能识别卒中症状(OR=2 249.238,P=0.032)是知道卒中溶栓治疗的独立预测因素。结论急性缺血性脑卒中患者对卒中危险因素、症状及溶栓治疗的认知率低,更高的文化程度和卒中高认知率有关。 Objective To explore the awareness of stroke warning signs,risk factors and thrombolytic therapy of acute ischemic stroke,and to determine the influential factors associated with the level of stroke knowledge.Methods Cross sectional surveys about the awareness of acute ischemic stroke were conducted with a structured questionnaire during March and Sept.2015.The relationship between the knowledge of stroke and pre-hospital delay,degree of neurological deficit,initial symptoms,response to stroke onset,status when stroke happened,previous medical history and demographic information were analyzed.Factors associated with stroke awareness were investigated with the help of univariate and multivariate regression analysis.Results A total of 138 acute ischemic stroke patients were interviewed,including 89 males and 49 females.The patients'mean age was 63.53±11.41 years.Weakness(60.1%)was the most commonly identified stroke sign,and hypertension(64.5%)was the most commonly identified stroke risk factors.Of all respondents,5.8% knew thrombolytic therapy and 1.4% knew thrombolytic time window.Univariate regression analysis demonstrated that educational level was associated with knowing three or more stroke risk factors(P =0.036),three or more stroke warning signs(P =0.042),thrombolytic therapy(P=0.045)and time window of thrombolytic therapy(P=0.017).Multivariate regression analysis indicated that recognizing initial symptom as stroke was the independent predictor of knowing three or more stroke risk factors(OR =0.252,P=0.012)and thrombolytic therapy(OR =2 249.238,P=0.032),taking informal antihypertensive drugs(OR =1.344,P =0.024),and using emergency medical services(EMS)as transporting pathway(OR=0.662,P=0.05)were independent factors of knowing three or more stroke signs.Conclusion The awareness of stroke warning signs,risk factors and thrombolytic therapy were obviously inadequate among acute ischemic stroke patients.Higher educational level was predictor of more stroke awareness.
出处 《国外医学(医学地理分册)》 CAS 2017年第2期115-121,共7页 Foreign Medical Sciences:Section of Medgeography
基金 甘肃省卫生行业科研计划项目(GSWST2012-03)
关键词 急性缺血性脑卒中 卒中认知 院前延迟 影响因素 回归分析 acute ischemic stroke stroke awareness pre-hospital delay related factors regression analysis
  • 相关文献

参考文献1

二级参考文献99

  • 1Wahlgren N, Ahrced N, Davalos A, et al; SITS-MOST Investigators. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITSMOST): an observational study. Lancet, 2007, 369: 275-282.
  • 2Lyden PD, ed. Thrombolytic Therapy for Acute Stroke. 2nd ed. Totowa, NJ: Hmreana Press, 2005.
  • 3Wardlaw JM, Smdercock PA, Berg: E. Throrrbolytic therapy with recoinbinant tissue plasminogen activator for acute ischemic stroke: where do we go from here? A cunaflative meta-analysis. Stroke, 2003, 34: 1437-1442.
  • 4Wardlaw JM, Zoppo G, Yamaguchi T, et al. Thrombolysis for acute ischaemic stroke. Cochrane Database Syst Rev, 2003, (4): CD000213.
  • 5Shanna M, Clark H, Armour T, et al. Acute stroke: evaluation and treatment. Evid Rep Technol Assess (Sunmm), 2005, (127): 1-7.
  • 6Hill MD, Buchan AM; Canadian Alteplase for Stroke Effectiveness Study (CASES) Investigators. Throrrbolysis for acute ischemic stroke: results of the Canadian Altephse for Stroke Effectiveness Study. CMAJ, 20(0, 172: 1307-1312.
  • 7Chung H, Refoios Canto R, Canto RR, et al. Alteplase for the treatment of acute ischaemic stroke: NICE technology appraisal guidance. Heart, 2007, 93: 1616-1617.
  • 8Saver JL, Smith EE, Fonarow GC, et al; GWTG-stroke Steering Committee and Investigators. The "golden hour" and acute brain ischemia: presenting features and lytic therapy in > 30,000 patients ariving within 60 minutes of stroke onset. Stroke, 2010, 41: 1431-1439.
  • 9Scott PA, Xu Z, Meurer WJ, et al. Attitudes and beliefs of Michigan emergmcy physicians toward tissue plasminogen activator use in stroke: baseline survey results from the INcreasing Stroke Treatment through INteractive behavioral Change Tactic (INSTINCT) trial hospitals. Stroke, 2010, 41: 2026-2032.
  • 10Kwiatkowski TG, Libman RB, Fmnkel M, et al. Effects of tissue plasrrfinogen activator for acute ischemic stroke at one year. National Institute of Neurological Disordeis and Stroke Recombinxaat Tissue Plasmiogen Activator Stroke Study Group. N Engl J Med, 1999, 340: 1781-1787.

共引文献984

同被引文献79

引证文献8

二级引证文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部